Michael Aragon, MD is Chief Medical Officer at Outset Medical, a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. Outset is the developer of The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, and represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers.
He is board certified in Internal Medicine and Nephrology, receiving his training at the University of Texas Health Sciences Center in Houston. His clinical research focus has been on the expansion and improvement of home dialysis options for patients with renal disease.
When facilities operate their own acute dialysis operations and no longer enlist third parties to provide treatment, they save hundreds of dollars per session. Insourcing also enables hospitals to keep trained dialysis staff on hand full-time to actively ensure quality kidney care to their patients.